		Clinical Features	Time to Death		AGE		NEOPLASM.DISEASESTAGE		PATHOLOGY.T.STAGE		PATHOLOGY.N.STAGE		PATHOLOGY.M.STAGE		GENDER		HISTOLOGICAL.TYPE		RADIATIONS.RADIATION.REGIMENINDICATION		RADIATIONEXPOSURE		EXTRATHYROIDAL.EXTENSION		COMPLETENESS.OF.RESECTION		NUMBER.OF.LYMPH.NODES		MULTIFOCALITY		TUMOR.SIZE	
	nMutated (%)	nWild-Type	logrank test_P	logrank test_Q	t-test_P	t-test_Q	Chi-square test_P	Chi-square test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	t-test_P	t-test_Q	Fisher's exact test_P	Fisher's exact test_Q	t-test_P	t-test_Q
NRAS	34 (9%)	358	0.46949	1	0.44814	1	0.049291	1	0.14881	1	0.00013809	0.0117	0.49153	1	0.83989	1	4.9671e-05	0.00432	0.61059	1	1	1	0.19206	1	0.65418	1	5.233e-05	0.0045	0.36874	1	0.65075	1
BRAF	236 (60%)	156	0.91014	1	0.66132	1	0.0020212	0.166	0.0006067	0.0504	0.00043041	0.0362	0.083451	1	0.40822	1	1.9384e-19	1.73e-17	0.032313	1	0.59201	1	3.7517e-07	3.3e-05	0.36501	1	0.56719	1	0.75308	1	0.3488	1
HRAS	13 (3%)	379	0.50729	1	0.59497	1	0.46351	1	0.4386	1	0.54909	1	0.28642	1	0.74648	1	0.012822	1	1	1	1	1	0.69124	1	0.17074	1	0.50744	1	0.77873	1	0.95428	1
EIF1AX	6 (2%)	386	0.096101	1	0.13722	1	0.96737	1	1	1	0.62507	1	0.4731	1	0.17608	1	0.0737	1	1	1	1	1	1	1	0.27522	1	0.76914	1	0.668	1	0.69009	1
NUP93	4 (1%)	388	0.9093	1	0.40771	1	0.78055	1	0.73611	1	0.34784	1	0.6586	1	1	1	0.014787	1	1	1	1	1	1	1	0.51192	1	0.61027	1	0.34349	1	0.98499	1
NLRP6	3 (1%)	389	0.64442	1	0.032757	1	0.81153	1	0.16962	1	0.60462	1	0.13425	1	1	1	0.65963	1	1	1	1	1	1	1	1	1	0.52534	1	0.60105	1	NA	NA
